|
India News Releases
|
(India.CityRegions.Com, October 22, 2016 ) Publisher's, "Soluble Guanylate Cyclase (sGC) Activators-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Soluble Guanylate Cyclase (sGC) Activators. The Publisher's Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Soluble Guanylate Cyclase (sGC) Activators. Publisher's Report also assesses the Soluble Guanylate Cyclase (sGC) Activators therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
Report Scope
- The report provides competitive pipeline landscape of Soluble Guanylate Cyclase (sGC) Activators - The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information - Coverage of the Soluble Guanylate Cyclase (sGC) Activators pipeline on the basis of target, MOA, route of administration, technology involved and molecule type - The report reviews key players involved in the therapeutics development for Soluble Guanylate Cyclase (sGC) Activators and also provide company profiling - The report also gives the information of dormant and discontinued pipeline projects - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
For more information http://www.reportsweb.com/soluble-guanylate-cyclase-sgc-activators-pipeline-insights-2016
Reason to Buy
- Complete MOA intelligence and complete understanding over therapeutics development for Soluble Guanylate Cyclase (sGC) Activators - Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. - Devise corrective measures for pipeline projects by understanding Soluble Guanylate Cyclase (sGC) Activators pipeline depth and focus of Indication therapeutics - Developing strategic initiatives to support your drug development activities. - Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business. - Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline - Gaining a Full Picture of the Competitive Landscape for Evidencebased Decisions
Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001338163/sample - Number of Products under Development for Soluble Guanylate Cyclase (sGC) Activators by Therapy Area, 2016 - Number of Products under Development for Soluble Guanylate Cyclase (sGC) Activators, 2016 - Number of Products under Development by Companies - Comparative Analysis by Filed and Phase III Products, 2016 - Comparative Analysis Phase II Products, 2016 - Comparative Analysis Phase I and IND Filed Products, 2016 - Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016 - Drug Candidates Profiles - Soluble Guanylate Cyclase (sGC) Activators Assessment by Monotherapy Products - Soluble Guanylate Cyclase (sGC) Activators Assessment by Combination Products - Soluble Guanylate Cyclase (sGC) Activators Assessment by Route of Administration - Soluble Guanylate Cyclase (sGC) Activators Assessment by Stage and Route of Administration - Soluble Guanylate Cyclase (sGC) Activators Assessment by Molecule Type - Soluble Guanylate Cyclase (sGC) Activators Assessment by Stage and Molecule Type - Soluble Guanylate Cyclase (sGC) Activators Therapeutics - Discontinued Products - Soluble Guanylate Cyclase (sGC) Activators Therapeutics - Dormant Products - Products under Development by Companies, 2016
-SWITCH Biotech LLC -Valeant Pharmaceuticals International Inc.
Make an enquiry: http://www.reportsweb.com/inquiry& RW0001338163/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
India RSS Feed Marketpalce
|
India News Headlines
Daily news from India: arts, business, culture, politics, science, technology & more.
Free Sales & Marketing Magazines
Get free publications about marketing, sales and customer relations management.
Submit RSS feed on India. Have your feed on news, products or services displayed under this marketpalce and have your feed on a full page updated daily.
|
|
India Business News by Major Cities
|
|
|
Listen to GroupWeb Radio
INDIA BUSINESS TV
|